Much research has gone into controlling or dampening the social and economic effects of the coronavirus disease 2019 (COVID-19) pandemic. Study: Inhaled aprotinin reduces viral load in ...

Rockville, MD - The US FDA has issued a public-health advisory alerting doctors who perform cardiac bypass surgery and their patients to two studies suggesting serious adverse events with aprotinin ...

San Bruno, CA - A new observational study has found that aprotinin (Trasylol, Bayer), used to reduce bleeding during cardiac surgery, is associated with serious end-organ damage, particularly renal ...

Aprotinin is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart ...

The blood saving-drug aprotinin appears safe during on-pump cardiac surgery. However, the combination of aprotinin and angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery is ...

A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin ...

A drug widely used to prevent excessive bleeding during heart surgery appears to raise the risk of dying in the five years afterward by nearly 50 percent, an international study found. The researchers ...

A popular drug given to more than a million people since 1993 to limit blood loss during heart surgery doubles a patient's risk of kidney failure and substantially increases the risk of a heart attack ...

COVID-19 is anticipated to keep causing regular outbreak waves for the foreseeable future. The recent COVID-19 waves have caused fewer hospitalizations and deaths than the initial ones, which is ...